Stock market announcement archive

Minutes from Extraordinary General Meeting

September 17, 2024
The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 17 September 2024. All proposals on the agenda were adopted, cf. the notification of the Extraordinary General Meeting that was published on Oslo Stock Exchange on 3 September 2024. The complete minutes of the Extraordinary General Meeting are attached and will […]
Read more

LIFECARE ASA: Extraordinary General Meeting

September 3, 2024
Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), will hold an Extraordinary General Meeting 17 September 2024, at 09:00 (CEST). For the planned uplisting from Euronext Growth Oslo to Oslo Børs, a share consolidation is required to meet the NOK 10 per share listing requirement. Additionally, to […]
Read more

Correction: LIFE: Lifecare ASA Q2 2024

August 30, 2024
Reference is made to the Q2 2024 report published by Lifecare ASA (the “Company”) on 27 August 2024. In connection with the uplisting to Euronext Oslo Børs, the Company has conducted new assessments of its financial statements and, in collaboration with its auditor, concluded to recognize the warrants issued in connection with the previously announced […]
Read more

LIFE: Lifecare ASA Q2 2024

August 27, 2024
Bergen, Norway, 27 August 2024: Today, Lifecare ASA (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q2 financial report and operational update. In the second quarter Lifecare continued to build positive momentum towards automatic production by delivering milestones on a continuous basis over a long […]
Read more

Lifecare ASA Q2 2024 presentation

August 22, 2024
Lifecare ASA will release its second quarter 2024 results on Tuesday 27 august 2024 at 07:00 a.m. CEST. The same day at 12:00 CEST, CEO Joacim Holter will present the results live at Carnegie AS, Fjordalleen 16, Aker Brygge in Oslo. After the presentation, Lifecare invites to 1:1 session with the CEO and the CFO. […]
Read more

LIFE – Successfully completed nine weeks of longevity trials

August 21, 2024
Bergen, Norway, 21 August 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from nine weeks of sensor longevity trials. Reference is made to press releases 18 June 2024 when the company initiated the trials with wireless readout. The Sencell sensor […]
Read more

LIFE: Strategic cooperation to make glucose data more accessible

August 13, 2024
Bergen, Norway, August 13, 2024: Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), is pleased to announce a strategic cooperation with OneTwo Analytics AB (OneTwo), a Swedish-based company specializing in data analytics of diabetes data. The strategic cooperation will provide Lifecare access to OneTwo’s portfolio of comprehensive […]
Read more

LIFE – Successfully completed four weeks of longevity trials

July 17, 2024
Bergen, Norway, 17 July 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from the first four week of sensor longevity trials. Reference is made to press releases 18 June 2024 when the company initiated the trials with wireless readout. The […]
Read more

Lifecare ASA: Share capital increase

July 5, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (“Lifecare” or the “Company”) on 14 June 2024 regarding the final results of the partially underwritten rights issue of new shares in the Company (the “Rights Issue”). The share capital increase pertaining to the issuance of 1,377,572 new shares to certain bottom underwriters […]
Read more